Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0900
+0.0050 (5.88%)
Dec 4, 2025, 5:26 PM EST
Britannia Life Sciences Revenue
Britannia Life Sciences had revenue of 111.87K CAD in the quarter ending September 30, 2025, a decrease of -52.31%. This brings the company's revenue in the last twelve months to 260.58K. In the fiscal year ending March 31, 2025, Britannia Life Sciences had annual revenue of 369.28K, down -28.55%.
Revenue (ttm)
260.58K
Revenue Growth
-28.55%
P/S Ratio
56.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 369.28K | -147.55K | -28.55% |
| Mar 31, 2024 | 516.83K | -5.89M | -91.93% |
| Mar 31, 2023 | 6.40M | -896.10K | -12.28% |
| Mar 31, 2022 | 7.30M | 5.88M | 412.42% |
| Mar 31, 2021 | 1.42M | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |